SEC Form 4/A · accession 0001209191-15-037194
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Cynthia M Butitta
Officer — COO and CFO
Period of report
Apr 27, 2015
Accepted (ET)
Apr 29, 2015 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2015 | M | 10,000 | $1.35 | A | 74,566 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option ( Right to Buy)F1 | $1.35 | Apr 27, 2015 | M | 10,000 | D | — | Mar 25, 2024 | Common Stock | 435,394 | 425,394 | D |
Explanation of responses
- F1108,839 shares subject to the stock option vested and became exercisable on December 15, 2014, and 9,071 shares vest each month thereafter.
Remarks
The transaction reported herein was inadvertently omitted from the Reporting Person's original Form 4 filed on the same date. For clarity, the number of shares of common stock beneficially owned following the reported transactions on this Form 4/A and the original Form 4 is 74,566.